CYSTORELIN DIN 02172704
Status: Cancelled Post Market
Holder: BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
Molecule: GONADORELIN DIACETATE TETRAHYDRATE
Health Canada record
| Active ingredient(s) | GONADORELIN DIACETATE TETRAHYDRATE 50 MCG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 01-Nov-1996 |
| Current status date | 05-Jul-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GONADORELIN DIACETATE TETRAHYDRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00497800 | CYSTORELIN INJ 50MCG/ML | P.V.U., DIVISION OF VÉTOQUINOL N.-A. INC. | Liquid | GONADORELIN DIACETATE TETRAHYDRATE 50 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 23756 | 2020-06-09 | New Drug Submission (NDS) | Administrative: Manufacturer Name Change |
| 12417 | 2011-06-09 | Supplement to a New Drug Submission (SNDS) | Change in withdrawal period |
| 6479 | 2000-02-14 | New Drug Submission (NDS) | |
| 7038 | 1995-09-15 | New Drug Submission (NDS) |
International API supply for GONADORELIN DIACETATE TETRAHYDRATE
0 active FDA Drug Master Files.
Request a quote for CYSTORELIN